Notable Analyst Rating Changes 11/28: THC, STD, FRO Upgraded; CHU, BCE, OVTI Downgraded
UPGRADES:
UBS upgrades Tenet Healthcare (NYSE: THC) from Sell to Neutral.
UBS upgrades Banco Santander (NYSE: STD) from Sell to Neutral.
UBS upgrades Frontline (NYSE: FRO) from Sell to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Credit Suisse downgrades China Unicom (NYSE: CHU) from Neutral to Underperform.
UBS downgrades BCE (NYSE: BCE) from Buy to Neutral.
Caris & Co. downgrades OmniVision Technologies (Nasdaq: OVTI) from Buy to Average.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Thomas Weisel initiates coverage on Cameco (NYSE: CCJ) with a Market Weight rating and a $22 price target.
Deutsche Bank reinstates coverage on BHP Billiton (NYSE: BHP) with a Buy.
Canaccord Adams initiates coverage on BCE (NYSE: BCE) with a Hold.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
Related Entities
- Credit Suisse
- Deutsche Bank
- UBS
- Canaccord Adams
- Thomas Weisel Partners Group
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
